Eunice Kennedy Shriver National Institute of Child Health and Human Development

News and Video Search Results

News coverage

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive

GlobeNewswire 11 Apr 2024

*Published data shows that Ovaprene was safe and effective in a postcoital test study of 33 women *

*Pivotal Phase 3..

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
GlobeNewswire 10 Apr 2024
Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
GlobeNewswire 10 Apr 2024
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
GlobeNewswire 04 Mar 2024
Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.
GlobeNewswire 06 Dec 2023

0 shares 1 views

You might like

Eunice Kennedy Shriver National Institute of Child Health and Human Development media coverage

UPDATE | Advanced imaging reveals altered brain chemistry of babies with congenital heart disease

GlobeNewswire 09 Oct 2023

New research provides hope for earlier intervention

WASHINGTON, D.C., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Researchers at..

Advanced imaging reveals altered brain chemistry of babies with congenital heart disease
GlobeNewswire 09 Oct 2023
The FNIH Awards 2023 Charles A. Sanders, M.D., Partnership Award to NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development, GSK, and the O’Neill Family
Business Wire 18 Sep 2023
Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH
Accesswire 17 Aug 2023
Scenic Biotech Enters Cooperative Research & Development Agreement with the National Institutes of Health for Genetic Modifier-Based Treatment Approach for Niemann-Pick Type C Disease
Business Wire 01 Feb 2023

Advertisement

More coverage

New Down Syndrome Resource Available in Spanish and Japanese

GlobeNewswire 29 Dec 2022

Global Down Syndrome Foundation, Centro UC Síndrome de Down and Japan Down Syndrome Association Join Forces to Translate & Provide..

BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication
GlobeNewswire 06 Dec 2022
New NIH-funded Study Will Investigate a Debilitating Condition Known as Down Syndrome Regression Disorder (DSRD)
GlobeNewswire 29 Sep 2022
US Clinical Trial Evaluating Antiviral For Monkeypox Begins
Eurasia Review 09 Sep 2022
Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women - Findings from HPTN 084 Study
GlobeNewswire 28 Jul 2022